However, some studies showed BRAF and NRAS mutations in the same tumor samples, suggesting that these mutations are not mutually exclusive in melanoma but exhibit intra-tumoral heterogeneity (Sensi et al., 2006; Jovanovic et al., 2010). The gene discussed is NRAS; the disease is melanoma.